NP5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Newron Pharmaceuticals SpA

Watchlist Manager

Watchlist

Price: 13.05 EUR -1.88%

Market Cap: €248.6m

	Newron Pharmaceuticals SpA F:NP5	IT
	Carbeeza Inc OTC:CRBAF	CA
A	Albis Leasing AG XBER:ALG	DE
	Advanced Blockchain AG F:ABX	DE
	Furuya Metal Co Ltd OTC:FRUYF	JP
T	Tekcapital PLC OTC:TEKCF	UK
C	CropEnergies AG XMUN:CE2	DE
	Shibaura Machine Co Ltd F:TOA	JP
O	One Liberty Properties Inc F:O1A	US

Profitability Summary

Newron Pharmaceuticals SpA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

95%

Declining Gross Margin

94% > 89%

Negative Operating Margin

-25%

Negative 3Y Average Operating Margin

-52%

Operating Margin is Increasing

-127% > -25%

Negative Net Margin

-69%

Negative 3Y Average Net Margin

-89%

Net Margin is Increasing

-180% > -69%

Exceptional Free Cash Flow Margin

169%

Negative 3Y Average Free Cash Flow Margin

-26%

Free Cash Flow Margin is Increasing

-127% > 169%

Exceptional ROE

274%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.